News

Emery Pharma Attending 2023 J.P. Morgan 41st Annual Healthcare Conference

ALAMEDA, CA. – Emery Pharma has announced that Ron Najafi, Ph.D., CEO of Emery Pharma, will be available during the JP Morgan Annual Healthcare Conference, held on January 9 – 11th,…

Read More

Nitrosamine Impurity Found in Januvia®, a Popular Diabetes Medication

A Nitrosamine impurity known as Nitroso-STG-19 (NTTP), has been identified in Januvia®, a popular diabetes drug developed by Merck & Co. Januvia® (sitagliptin), is an oral medication used to treat…

Read More

Newswire Press Release: Announcing New Biologics Analytical Division

Supporting end-to-end research and development of large molecule drugs including, biologics, antibody-drug conjugates, biosimilars, and more. Alameda, CA –Emery Pharma has officially expanded its state-of-the-art laboratories which feature a brand-new High-resolution…

Read More

Celebrating 10 years!

Alameda, CA-Emery Pharma is proudly celebrating its 10th anniversary. Over the last decade, we have supported over 300 clients, from virtual start-ups to the top 5 largest global companies. We…

Read More

FDA Citizen Petition on Vitamin B6: Press Coverage

October 27, 2021- Press coverage regarding Emery Pharma’s Citizen Petition with the FDA on high-dose Vitamin B6 supplements available over-the-counter. WebMD: Does Vitamin B6 Need a Warning Label? Vitamin B6,…

Read More

PR Newswire: Vitamin B6 Toxicity

Alameda, CA- September 20, 2021 Emery Pharma filed a Citizen Petition with the FDA requesting the agency to recall all over-the-counter “mega dose” Vitamin B6, due to the risk of…

Read More

Vertosa Announces U.S. Patent, Engages Emery Pharma for Research That Applies Their Pharmaceutical Development Expertise to Cannabis-Infused Products

ALAMEDA/OAKLAND, CA – Vertosa, a science-first cannabis company that creates the most effective and reliable active ingredients for infused products, today announced the United States patent for one of its…

Read More

Press Coverage by WebMD Regarding Ranitidine Recall

Alameda, CA – WebMD, LLC recently interviewed Emery Pharma’s CEO, Dr. Ron Najafi, to share his thoughts about this covered story and the recently retracted publication in the Carcinogenesis journal….

Read More

Dr. Ron Najafi of Emery Pharma Mentioned in Silver Bullet Therapeutics Press Release

Alameda, CA — Silver Bullet Therapeutics posted a press release with mention of Emery Pharma’s CEO, Dr. Ron Najafi. Emery Pharma supported Silver Bullet Therapeutics with various antimicrobial resistance studies…

Read More

Emery Pharma Sponsors 2021 R. Bryan Miller Symposium

Davis, CA: Emery Pharma, a full-service contract research laboratory, sponsors UC Davis Department of Chemistry’s annual R. Bryan Miller Symposium on February 26, 2021. More information about the event is…

Read More